Repeat large panel genomic sequencing identifies actionable alterations and characterizes the genomic landscape in patients with metastatic solid tumors.

Authors

null

Niamh Coleman

The University of Texas MD Anderson Cancer Center, Houston

Niamh Coleman , Timothy P. DiPeri , Daniel Nguyen , Aung Naing , Sarina Anne Piha-Paul , Apostolia Maria Tsimberidou , Xiaofeng Zheng , Amber Johnson , Wanlin Wang , Kenna R. Shaw , Ecaterina Elena Dumbrava , Siqing Fu , Jordi Rodon Ahnert , David S. Hong , Vivek Subbiah , Timothy A. Yap , Rajyalakshmi Luthra , Keyur P. Patel , Funda Meric-Bernstam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3076)

DOI

10.1200/JCO.2022.40.16_suppl.3076

Abstract #

3076

Poster Bd #

68

Abstract Disclosures

Similar Posters

First Author: Pradeep Poonnen

Poster

2014 Gastrointestinal Cancers Symposium

Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity—Pangea.

Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity—Pangea.

First Author: Daniel Virgil Thomas Catenacci